Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Taking the direct approach in hepatitis C

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Taking the direct approach in hepatitis C. Pharmacoecon. Outcomes News 656, 3–4 (2012). https://doi.org/10.2165/00151234-201206560-00003

    Download citation


    • Sustained Virologic Response
    • Sustained Virologic Response Rate
    • Telaprevir
    • Boceprevir
    • Improve Sustained Virologic Response Rate